Generics and Biosimilars: Barriers and Opportunities

Mayo Clin Proc. 2021 Dec;96(12):2947-2957. doi: 10.1016/j.mayocp.2021.08.001. Epub 2021 Oct 30.

Authors

Caleb J Scheckel¹, S Vincent Rajkumar²

Affiliations

¹ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN. Electronic address: Scheckel.caleb@mayo.edu.
² Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

PMID: 34728057
DOI: 10.1016/j.mayocp.2021.08.001

No abstract available

Publication types

Video-Audio Media

MeSH terms

Biosimilar Pharmaceuticals / economics
Biosimilar Pharmaceuticals / therapeutic use*
Drug Costs / legislation & jurisprudence
Drugs, Generic / economics
Drugs, Generic / therapeutic use*
Humans
Patents as Topic
United States

Substances

Biosimilar Pharmaceuticals
Drugs, Generic